Sugden PH |
Signalling pathways in cardiac myocyte hypertrophy. |
2001 |
Ann. Med. |
pmid:11817656
|
Sun L et al. |
Cellular and molecular consequences of calcineurin A alpha gene deletion. |
2007 |
Ann. N. Y. Acad. Sci. |
pmid:17872390
|
Shipston MJ et al. |
Glucocorticoid negative feedback in pituitary corticotropes. Pivotal role for calcineurin inhibition of adenylyl cyclase. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7529975
|
Iwanaga Y et al. |
Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:17130575
|
Xu L et al. |
Potential for pharmacology of ryanodine receptor/calcium release channels. |
1998 |
Ann. N. Y. Acad. Sci. |
pmid:10603942
|
Bers DM et al. |
Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. |
1998 |
Ann. N. Y. Acad. Sci. |
pmid:10603944
|
Engelbrecht ME et al. |
The effect of immunosuppressants on human leukocyte NADPH oxidase. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7518204
|
Zuany-Amorim C et al. |
Modulation by rm interferon-gamma and CD4+ T-lymphocytes of allergic eosinophil accumulation in the mice peritoneal cavity. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7518212
|
Nagai H et al. |
The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. |
1996 |
Ann. N. Y. Acad. Sci. |
pmid:8906215
|
Clipstone NA and Crabtree GR |
Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509131
|
Takahara S |
Efficacy of FK506 in renal transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509132
|
Thomson AW et al. |
Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509133
|
Lemster B et al. |
FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509134
|
Tamura K et al. |
Inhibitory effect of FK 506 on autoimmune thyroid disease in the PVG rat. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509135
|
Ochiai T et al. |
Combination of immunosuppressive drugs for organ transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509136
|
Wiederrecht G et al. |
The mechanism of action of FK-506 and cyclosporin A. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509138
|
Lee RK and Wurtman RJ |
Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors. |
2000 |
Ann. N. Y. Acad. Sci. |
pmid:11193162
|
Christensen BG |
FK-506: its role in immunosuppression. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689803
|
Kino T and Goto T |
Discovery of FK-506 and update. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689804
|
Parsons WH et al. |
FK-506--a novel immunosuppressant. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689805
|
Zenke G et al. |
Molecular mechanisms of immunosuppression by cyclosporins. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689806
|
Clardy J |
Structural studies of complexed FK-506 binding protein. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689808
|
Starzl TE et al. |
Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689809
|
Reem GH et al. |
FK-506 inhibits the IL-2-independent induction of the activation antigen CD 69. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689811
|
Mollison KW et al. |
Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689812
|
Ponseti JM et al. |
Tacrolimus for myasthenia gravis: a clinical study of 212 patients. |
2008 |
Ann. N. Y. Acad. Sci. |
pmid:18096852
|
Paterson DL et al. |
Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? |
1997 |
Ann. Neurol. |
pmid:9266742
|
Caprariello AV et al. |
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. |
2012 |
Ann. Neurol. |
pmid:23034912
|
Keswani SC et al. |
FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. |
2003 |
Ann. Neurol. |
pmid:12509848
|
Dawson TM |
Immunosuppressants, immunophilins, and the nervous system. |
1996 |
Ann. Neurol. |
pmid:8871573
|
Small SL et al. |
Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506) |
1996 |
Ann. Neurol. |
pmid:8871576
|
Roberts WK et al. |
A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. |
2015 |
Ann. Neurol. |
pmid:26224283
|
Wijdicks EF et al. |
FK506-induced neurotoxicity in liver transplantation. |
1994 |
Ann. Neurol. |
pmid:7512320
|
Nelson M et al. |
Direct revascularization is superior for rat parathyroid allotransplantation with FK506. |
2005 |
Ann. Otol. Rhinol. Laryngol. |
pmid:15825570
|
Gerster JC et al. |
Gout in liver transplant patients receiving tacrolimus. |
2004 |
Ann. Rheum. Dis. |
pmid:15194597
|
Igarashi T et al. |
Central nervous system toxicity related to FK506 in patients with Behçet's disease. |
1994 |
Ann. Rheum. Dis. |
pmid:7517134
|
Villaverde V et al. |
Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506) |
1999 |
Ann. Rheum. Dis. |
pmid:10577370
|
Duddridge M and Powell RJ |
Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. |
1997 |
Ann. Rheum. Dis. |
pmid:9462174
|
Lightman S et al. |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. |
2015 |
Ann. Rheum. Dis. |
pmid:25269831
|
Lampropoulos CE and D' Cruz DP |
Topical tacrolimus treatment in a patient with dermatomyositis. |
2005 |
Ann. Rheum. Dis. |
pmid:16100347
|
Mok CC et al. |
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. |
2016 |
Ann. Rheum. Dis. |
pmid:25550339
|
Schlegel A et al. |
Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. |
2014 |
Ann. Surg. |
pmid:25243553
|
Todo S et al. |
Liver, kidney, and thoracic organ transplantation under FK 506. |
1990 |
Ann. Surg. |
pmid:1697743
|
Ozawa K et al. |
An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. |
1992 |
Ann. Surg. |
pmid:1280074
|
Vivarelli M et al. |
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. |
2008 |
Ann. Surg. |
pmid:18948815
|
Petruzzo P et al. |
Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. |
2015 |
Ann. Surg. |
pmid:24646555
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Jain A et al. |
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. |
1999 |
Ann. Surg. |
pmid:10493490
|
Lerut J et al. |
Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. |
2008 |
Ann. Surg. |
pmid:19092340
|
Todo S et al. |
Intestinal transplantation in composite visceral grafts or alone. |
1992 |
Ann. Surg. |
pmid:1384443
|